Research map: Cross-Correction in HSC Gene Therapy for Metachromatic Leukodystrophy

Back to the article

Papers in this map

  1. Metachromatic leukodystrophy and transplantation: remyelination, no cross‐correction · Nicole I. Wolf · 2020 · 84 citations · Cited by this paper
  2. Health Care–Associated Infections in U.S. Hospitals, 2023 versus 2015 · 2026 · Related
  3. Human iPSC-based models highlight defective glial and neuronal differentiation from neural progenitor cells in metachromatic leukodystrophy · Giacomo Frati · 2018 · 50 citations · Cited by this paper
  4. Phase 3 Trial of Weekly Oral Islatravir–Lenacapavir for HIV-1 Treatment · 2026 · Related
  5. Secretion of phosphomannosyl-deficient arylsulphatase A and cathepsin D from isolated human macrophages · Nicole Muschol · 2002 · 38 citations · Cited by this paper
  6. Mineralocorticoid Receptor Antagonism — FINDing Another Benefit · 2026 · Related
  7. Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy · Francesca Fumagalli · 2025 · 30 citations · Cited by this paper
  8. Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer · 2026 · Related
  9. Brain cell type-specific endocytosis of arylsulfatase A identifies limitations of enzyme-based therapies for metachromatic leukodystrophy · Debora Kaminski · 2020 · 16 citations · Cited by this paper
  10. Time to Stop? Rethinking the Duration of Maintenance Treatment in Multiple Myeloma · 2026 · Related
  11. Transdermal Estradiol Patches in Prostate Cancer · 2026 · Related
  12. Left Ventricular Unloading in High-Risk PCI · 2026 · Related
  13. Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma · 2026 · Related
  14. Koebner Phenomenon from Wet Cupping · 2026 · Related
  15. More on Digital Twin–Guided Ablation for Ventricular Tachycardia · 2026 · Related

Source: OpenAlex (CC0)